CLOSE
MENU
News Releases
Hands typing on computer keyboard
Hands typing on computer keyboard

Historical Archives

Explore all Bausch + Lomb news.

Published Date Short Description
05/03/22 Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting Read more »
04/28/22 Bausch + Lomb Corporation Announces Launch of IPO and Roadshow Read more »
04/28/22 Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation Read more »
04/28/22 Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting Read more »
04/25/22 Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting Read more »
04/21/22 Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs Read more »
04/20/22 Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch Health Read more »
04/18/22 Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting Read more »
03/28/22 Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis Read more »
02/23/22 Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance Read more »
02/03/22 Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 Read more »
02/01/22 Bausch + Lomb and Prevent Blindness Launch Annual AMD Awareness Month Campaign To Educate Patients Read more »
01/20/22 Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer Read more »
01/13/22 Bausch + Lomb Corporation Files Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering Read more »
01/11/22 Bausch Health Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference Read more »
1/4/2022 New Survey from Bausch + Lomb and Glaucoma Research Foundation Reveals Emotional and Social Impact of Hyperemia on Glaucoma Patients Read more »
11/15/2021 Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs Read more »
11/2/2021 Bausch Health Companies Inc. Announces Third-Quarter 2021 Results Read more »
11/1/2021 Bausch + Lomb Will Present Scientific Data and Analyses During the American Academy of Ophthalmology and American Academy of Optometry Annual Meetings Read more »
10/27/2021 Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration With TerraCycle in the United States Read more »
10/25/2021 Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Assoc Read more »
10/6/2021 Bausch Health Companies Inc. Will Release Third-Quarter 2021 Financial Results On November 2 Read more »
9/30/2021 Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysf Read more »
9/29/2021 Bausch Health Releases Annual Environmental, Social and Governance Report Read more »
08/03/2021 Bausch Health Companies Inc. Announces Second-Quarter 2021 Results Read more »
7/19/2021 Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refracti Read more »
07/19/2021

Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving its Surgical Technologies at the 2021 Annual Meeting of the American Society of Cataract and Refractive Surgery

 Read more »
7/12/2021 Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes Read more »
7/7/2021 Bausch + Lomb Completes Enrollment of Second Phase 3 Study For NOV03 (perfluorohexyloctane) Read more »
07/06/2021 Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3 Read more »
6/23/2021 Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Read more »
6/8/2021 Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software Read more »
6/2/2021 Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) Read more »
6/1/2021 Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month Read more »
5/11/2021 New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression Read more »
05/04/2021 Bausch Health Companies Inc. Announces First-Quarter 2021 Results Read more »
4/29/2021 Bausch + Lomb Will Present New Scientific Data And Analyses On Products And Pipeline Programs During The Association For Research In Vision And Ophthalmology Meeting Read more »
04/16/2021 Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved In Brazil Read more »
4/13/2021 Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfu Read more »
04/09/2021 Bausch Health Companies Inc. Will Release First-Quarter 2021 Financial Results On May 4 Read more »
4/7/2021 FDA Approves Bausch + Lomb ClearVisc™ Dispersive Ophthalmic Viscosurgical Device Read more »
02/24/2021 Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved in South Korea Read more »
2/23/2021 Bausch + Lomb Launches Alaway® Preservative Free Antihistamine Eye Drops Read more »
2/9/2021 Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance Read more »
2/1/2021 Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD) Read more »
01/21/2021 South Korea's MFDS Approves LUMIFY® Eye Drops Read more »
1/20/2021 Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium < Read more »
1/19/2021 Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 (perfluorohexyloctane) Read more »
01/12/2021 Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery Read more »
11/24/2020 Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction Read more »
11/16/2020 Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride Read more »
11/12/2020 Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through ONE By ONE Recycling Program Read more »
11/10/2020

Bausch + Lomb Highlights Surgical, Pharmaceutical and Consumer Health Care Innovations and New Business Ventures; Offers Educational Opportunities During The Annual Meeting of The American Academy of Ophthalmology

 Read more »
11/3/2020 Bausch Health Companies Inc. Announces Third-Quarter 2020 Results Read more »
10/27/2020 Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses Read more »
10/15/2020 Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens Read more »
10/12/2020 Bausch Health Licenses Eyenovia''s Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 Read more »
10/8/2020 Bausch Health Companies Inc. Provides Preliminary Update On Third-Quarter 2020 Financial Results And Business Recovery Read more »
10/6/2020 Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses During The American Academy Of Read more »
10/1/2020 Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List Read more »
9/25/2020 FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035% Read more »
9/24/2020 Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries Read more »
09/23/2020 Bausch Health Releases Annual Corporate Social Responsibility Report Read more »
9/21/2020 Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics Read more »
09/16/2020 Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference Read more »
9/10/2020 Bausch Foundation Releases Inaugural Activity Report Read more »
08/18/2020 Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses Read more »
8/17/2020 Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses Read more »
08/11/2020 Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses Read more »
08/06/2020 Bausch Health Companies Inc. Announces Second-Quarter 2020 Results Read more »
08/06/2020 Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company Read more »
08/05/2020

Bausch + Lomb Launches -2.75 Cylinder For Biotrue® ONEday For Astigmatism Daily Disposable Contact Lenses

 Read more »
07/21/2020

Bausch + Lomb Introduces Pinnacle 360™ 25-gauge Scleral Fixation Forceps

 Read more »
07/20/2020

Bausch + Lomb Licenses Orthokeratology Lens System from Katt Design Group

 Read more »
06/17/2020 BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China Read more »
6/4/2020 FDA Provides 510(k) Clearance For Bausch + Lomb INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses Read more »
05/27/2020 Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses Read more »
05/07/2020 Bausch Health Companies Inc. Announces First-Quarter 2020 Results Read more »
05/06/2020

Bausch + Lomb Licenses Exclusive Rights from STADA and Xbrane to a Biosimilar Candidate for Lucentis (ranibizumab) in the United States and Canada

 Read more »
4/23/2020 Bausch Health Companies Inc. Will Release First-Quarter 2020 Financial Results On May 7 Read more »
4/14/2020 Bausch + Lomb Announces Publication Of 10-Year ARMOR Study Results On Ocular Antibiotic Resistance in JAMA Ophthalmology Read more »
03/24/2020 Bausch Health Donates Health Care Products And Supplies Through Bausch Foundation In Response To COVID-19 Pandemic Read more »
02/19/2020 Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance Read more »
2/3/2020 Bausch + Lomb And Prevent Blindness Join Together To Raise Awareness And Provide Educational Resources For February's Age-Related Macular Degeneration Awareness Month Read more »
1/28/2020 Bausch Health and Clearside Biomedical Announce Publication of Pivotal Phase 3 Data on XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology Read more» Read more »
01/16/2020 Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2019 Financial Results on February 19 Read more »
01/13/2020 Bausch Health Publishes Company Update for the 38th Annual J.P. Morgan Healthcare Conference Read more »
1/6/2020 Bausch + Lomb Launches Expanded Parameters for Biotrue® ONEday for Astigmatism Daily Disposable Contact Lenses Read more »
12/20/2019 Bausch Health Licenses Novaliq''s NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction Read more »
12/17/2019 Bausch + Lomb Initiates Clinical Trial Evaluating New Cohesive Ophthalmic Viscosurgical Device (OVD) For Use In Cataract Surgery Read more »
12/17/2019

Bausch + Lomb Initiates Clinical Trial Evaluating New Cohesive Ophthalmic Viscosurgical Device (OVD)

 Read more »
12/11/2019 Bausch + Lomb Introduces enVista® Toric MX60ET Intraocular Lens With StableFlex™ Technology Read more »
11/13/2019 Bausch + Lomb and TerraCycle Announce Donation of New Custom Training Modules Incorporating Used Contact Lens Materials to Guide Dog Foundation Read more »
11/4/2019 Bausch Health Companies Inc. Announces Third-Quarter 2019 Results and Raises Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance Ranges Read more »
10/23/2019 Bausch Health Licenses Clearside Biomedical''s XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis Read more »
10/22/2019

Bausch + Lomb To Present New Data During The American Academy of Optometry Meeting in Orlando

 Read more »
10/21/2019 Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins Read more »
10/16/2019

Bausch + Lomb Expands Parameter Offering For Biotrue® ONEday Daily Disposable Contact Lenses

 Read more »
10/07/2019

Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy of Ophthalmology Meeting in San Francisco

 Read more »
10/7/2019 Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy Of Ophthalmology And American Academy Of Optometry Annual Meetings Read more» Read more »
10/4/2019 Bausch Health Companies Inc. Will Release Third-Quarter 2019 Financial Results on November 4 Read more »
9/10/2019 Bausch Health Releases 2018 Corporate Social Responsibility Report Read more »
8/6/2019 Bausch Health Companies Inc. Announces Second-Quarter 2019 Results And Raises Full-Year Guidance Read more »
07/31/2019

Bausch + Lomb Initiates First Clinical For Technolas® Teneo™ Excimer Laser in The United States

 Read more »
07/24/2019

Bausch + Lomb Showcases New Retina Innovations at In-Booth Wet Lab During The Annual Meeting of The American Society of Retina Specialists

 Read more »
07/23/2019

Bausch + Lomb Introduces FreeFlow™ Infusion System For Retina Surgery

 Read more »
07/22/2019

Bausch + Lomb Introduces 23-Gauge Bi-Blade® Dual Port Vitrectomy Cutter For The Stellaris Elite™ Vision Enhancement System

 Read more »
7/9/2019 Bausch + Lomb Announces U.S. Launch Of Ocuvite® Eye Performance Vitamins Read more »
7/8/2019 Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6 Read more »
6/19/2019

Bausch + Lomb ULTRA® Multifocal For Astigmatism Contact Lenses Now Available For The First Time As A Standard Offering in Fit Sets

 Read more »
6/19/2019 Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Now Available In the United States Read more »
5/6/2019 Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance Read more »
4/29/2019

Bausch + Lomb Announces Update From Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study

 Read more »
4/29/2019 Bausch + Lomb Announces New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented During the Annual Meeting of the American Society Of Cataract and Refr Read more »
4/26/2019 New Scientific and Clinical Analyses Regarding Bausch + Lomb Surgical And Pharmaceutical Products To Be Presented During the Association For Research In Vision and Ophthalmology Meeti Read more »
4/22/2019 Bausch + Lomb Reports More Than 9.2 Million Units Of Contact Lens Materials Diverted From Waste Stream Through ONE By ONE Recycling Program Read more »
4/8/2019 Bausch Health Companies Inc. Will Release First-Quarter 2019 Financial Results On May 6 Read more »
4/2/2019 Bausch + Lomb Announces the U.S. Launch Of LOTEMAX® SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% for the Treatment Of Postoperative Inflammation and Pain Following Ocular Surgery Read more »
2/25/2019 Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% for the Treatment Of Postoperative Inflammation and Pain Following Ocular Surgery < Read more »
2/20/2019 Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance Read more »
2/19/2019 Bausch Health Acquires Eton Pharmaceuticals'' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies Read more »
2/13/2019 Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible® Hydra-PEG® Custom Contact Lens Coating Technology On Several Of Its Boston® Gas Permeable Lens Materials And Zenlens™ Read more »
2/4/2019 Bausch + Lomb Launches SightMatters.com To Help People Living With Age-Related Macular Degeneration Take Control Of Their Condition Read more »
1/22/2019

Bausch + Lomb Introduces ZEN™ Multifocal Scleral Lens for Presbyopia

 Read more »
1/18/2019 Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2018 Financial Results On February 20 Read more »
1/7/2019 Bausch Health Provides Company Update At The 37th Annual J.P. Morgan Healthcare Conference Read more »
12/5/2018 Bausch + Lomb Receives 510(K) Clearance From FDA For Bausch + Lomb ULTRA® Multifocal For Astigmatism Contact Lenses Read more »
12/4/2018

Bausch + Lomb Announces Exclusive Agreement with Modulight to Develop New Photodynamic Laser

 Read more »
11/15/2018 Bausch + Lomb Reports More Than Five Million Units Of Contact Lens Materials Recycled By Second Anniversary Of ONE By ONE Recycling Program Read more »
11/13/2018 Bausch Health Will Expand Contact Lens Manufacturing Facilities In Rochester, NY And Waterford, Ireland Read more »
11/7/2018 Bausch Health Commences Cash Tender Offer And Consent Solicitation For Any And All Of Its 7.500% Senior Notes Due 2021 Read more »
11/6/2018 Bausch Health Companies Inc. Announces Third-Quarter 2018 Results Read more »
11/6/2018

Bausch + Lomb to Present New Scientific Data During the American Academy of Optometry Meeting in San Antonio

 Read more »
10/24/2018 Bausch + Lomb To Launch First-In-Class Surgical Support Applications For Stellaris Elite™ Vision Enhancement System On IBM Cloud Read more »
10/23/2018 Bausch Health Announces Endowment With The University Of Missouri To Support Student Scholarships Read more »
10/16/2018 Bausch + Lomb Announces Completion of 100th Clinical Case Using Vitesse® Hypersonic Vitrectomy System on Stellaris Elite™ Vision Enhancement System Read more »
10/12/2018 Bausch Health Companies Inc. Will Release Third-Quarter 2018 Financial Results On November 6 Read more »
9/27/2018 Bausch Health Releases First Annual Corporate Social Responsibility Report Read more »
9/10/2018 LUMIFY™ Redness Reliever Eye Drops Honored By The National Association of Chain Drug Stores As Product Showcase Winner Read more »
9/5/2018 Bausch + Lomb Announces Publication Of Pivotal Phase 3 Data On Loteprednol Etabonate Ophthalmic Gel, 0.38% In Journal Of Cataract And Refractive Surgery Read more »
8/27/2018 Bausch + Lomb Launches Expanded Parameters of Biotrue® ONEday for Astigmatism Contact Lenses  Read more »
8/20/2018 Joseph Gordon Named U.S. President of Bausch + Lomb Read more »
8/7/2018 Bausch Health Companies Inc. Announces Second-Quarter 2018 Results Read more »
7/24/2018 Bausch + Lomb Relocates Company Archive to New Space in Rochester, NY Optics Center Facility, Showcasing 165 Years of Science and Innovation Read more »
7/18/2018 Bausch Health Companies Will Release Second-Quarter 2018 Financial Results On August 7 Read more »
7/16/2018 Bausch Health Companies Inc. Begins Trading Today as "BHC" on NYSE and TSX Read more »
7/13/2018 Bausch Health Companies Inc. completes name change Read more »
7/9/2018 Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38% Read more »
6/25/2018 Bausch + Lomb Announces Licensing Agreement With Tangible Science For Use of Tangible Hydra-Peg Custom Contact Lens Coating Technology Read more »
6/18/2018 Bausch + Lomb Launches -2.75D Cylinder Power for Bausch + Lomb ULTRA® for Astigmatism Contact Lenses, the Fastest Growing Family of Monthly Planned Replacement Lenses Read more »
6/18/2018 Bausch + Lomb Receives FDA Pre-Market Approval For enVista® Toric MX60T Intraocular Lens Read more »
6/14/2018 Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops Read more »
6/12/2018 Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins Read more »
6/4/2018 Bausch + Lomb Enrolls First Patient in enVista® MX60EF Trifocal IOL Clinical Trial Read more »
5/9/2018 Bausch + Lomb Initiates Clincal Trial Evaluating New Ophthalmic Viscosurgical Device (OVD) Read more »
5/8/2018 Valeant Will Become Bausch Health Companies Inc. Read more »
5/8/2018 Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance Read more »
5/7/2018 Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose Brimonidine Read more »
5/2/2018 Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for Extended Wear Indication Read more »
5/2/2018 Bausch + Lomb Receives FDA Approval of Extended Wear Indication for Bausch + Lomb ULTRA® Family of Contact Lenses Read more »
5/2/2018 Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Study Read more »
5/1/2018 Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Chewable Vitamins Read more »
4/27/2018 Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting Read more »
4/19/2018 Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE By ONE Program Read more »
4/19/2018 Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program, Saves More Than 14,000 Pounds of Waste Read more »
4/18/2018 Bausch + Lomb Receives 510(K) Clearance From FDA For BOSTON® Scleral Lens Case Read more »
4/11/2018 Bausch + Lomb to Showcase Latest Innovations, New Scientific Data During the Annual Meeting of the American Society of Cataract And Refractive Surgery Read more »
4/11/2018 Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery Read more »
4/6/2018 Valeant Will Release First-Quarter 2018 Financial Results On May 8 Read more »
3/22/2018 Bausch + Lomb Introduces 25- and 27-Gauge Bi-Blade® Dual Port Vitrectomy Cutters for the Stellaris Elite™ Vision Enhancement System Read more »
3/12/2017 Bausch + Lomb Signs Agreement with Express Scripts, Inc. Expanding Insurance Coverage of VYZULTA™ (latanoprostene bunod ophthalmic solution), 0.024% Read more »
2/28/2018 Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance Read more »
2/28/2018 Bausch + Lomb Signs Agreement with IDOC to Expand Offering of Leading Contact Lenses and Specialty Vision Products Read more »
2/28/2018 Bausch + Lomb Signs Agreement with IDOC to Expand Offering of Leading Contact Lenses and Specialty Vision Products Read more »
2/6/2018 Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 Read more »
2/6/2018 Bausch + Lomb and the Organization, Prevent Blindness® Encourage People to Fight for Their Sight During February, AMD Awareness Month Read more »
1/17/2018 Bausch + Lomb Receives FDA Approval of LUMIFY™ – The Only Over-The-Counter (OTC) Eye Drop With Low-Dose Brimonidine For The Treatment of Ocular Redness Read more »
1/9/2018 Valeant Provides Company Update At The 36th Annual J.P. Morgan Healthcare Conference Read more »
1/8/2018 Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite™ Vision Enhancement System, Including The Vitesse™ Vitrectomy System Read more »
1/2/2018 BAUSCH + LOMB RECEIVES 510(k) Clearance FOR CRYSTALSERT® 2.6 INJECTOR for Crystalens®AO and Trulign® Toric IOLs

 Read more »
1/2/2018 Bausch + Lomb Receives 510(k) Clearance for Crystalsert® 2.6 Injector for Crystalens®AO AND Trulign® Toric IOLS Read more »
12/22/2017 Bausch + Lomb Receives FDA Approval of LUMIFY™ - The Only Over-The-Counter Eye Drop With Low-Dose Brimonidine For The Treatment Of Eye Redness Read more »
12/18/2017 Bausch + Lomb Begins Distribution Of VYZULTA™ (latanoprostene bunod ophthalmic solution), 0.024% To U.S. Wholesalers Read more »
11/15/2017 Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program Read more »
11/13/2017 Bausch + Lomb Launches Expanded Parameters of Bausch + Lomb ULTRA® for Astigmatism Contact Lenses Read more »
11/7/2017 Valeant Announces Third-Quarter 2017 Results Read more »
11/7/2017 Three Interactive Exhibits Showcase Bausch + Lomb Innovations and Focus on Customers, Patients During the Annual Meeting of the American Academy of Ophthalmology in New Orleans Read more »
11/2/2017 Bausch + Lomb And Nicox Announce FDA Approval Of VYZULTA™ (latanoprostene Bunod Ophthalmic Solution), 0.024% Read more »
11/1/2017 Bausch + Lomb Announces FDA Filing of Extended Wear Indication for Bausch + Lomb ULTRA® Family of Contact Lenses Read more »
10/24/2017 Bausch + Lomb Receives 510(K) Clearance From FDA on New 3.3 Software for VICTUS® Femtosecond Laser Read more »
10/16/2017 Bausch + Lomb Introduces enVista® MX60E Intraocular Lens Read more »
10/3/2017 Valeant Will Release Third-Quarter 2017 Financial Results On November 7 Read more »
10/3/2017 Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe Read more »
9/6/2017 Bausch + Lomb Introduces Ocuvite® Eye Vitamin Adult 50+ Formula Minigels Read more »
8/9/2017 Bausch + Lomb Receives 510(k) Clearance from FDA for the Therapeutic Use of Boston XO® and Boston XO2® materials Read more »
8/8/2017 Valeant Announces Second-Quarter 2017 Results Read more »
8/7/2017 Valeant Pharmaceuticals Receives Complete Response Letter from the FDA for Latanoprostene Bunod Ophthalmic Solution, 0.024% NDA Read more »
8/7/2017 Bausch + Lomb Launches Stellaris Elite™ for Retina Surgery Read more »
7/17/2017 Bausch + Lomb Launches Innovative Contact Lens Patient Savings & Rewards Program Read more »
7/12/2017 Bausch + Lomb Launches FortifEYE™ Capsular Tension Ring Preloaded Single-use Injector Simplifies CTR Implantation Read more »
7/6/2017 Bausch + Lomb Japan Launches Bausch + Lomb AQUALOX® Contact Lenses Read more »
6/22/2017 Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International Read more »
6/20/2017 Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry’s Meeting Read more »
5/22/2017 Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution Read more »
5/10/2017 Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study Read more »
5/9/2017 Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range Read more »
5/8/2017 Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025% Read more »
5/3/2017 Bausch + Lomb Invites Surgeons to “Test Drive” New Next-Generation Phacoemulsification Platform at the American Society of Cataract and Refractive Surgery in Los Angeles Read more »
4/26/2017 Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic, Open-Port Vitrectomy System Read more »
4/10/2017 Valeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call Read more »
4/6/2017 Bausch + Lomb Receives 510(k) Clearance From FDA For Stellaris Elite™ Next-Generation Phacoemulsification Platform Read more »
3/30/2017 Bausch + Lomb ULTRA® for Astigmatism Contact Lenses Introduced Read more »
3/30/2017 Bausch + Lomb Announces U.S. Management Team Leadership Read more »
3/30/2017 Introducing Bausch + Lomb ULTRA® for Astigmatism Contact Lenses Read more »
3/20/2017 Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod Read more »
3/15/2017 Bausch + Lomb Introduces Biotrue® ONEday For Astigmatism Contact Lenses Read more »
3/1/2017 Bausch + Lomb Educates Over 200 Eye Care Professionals During B+Lieve™ Symposium in San Francisco, CA Read more »
2/28/2017 Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance Read more »
2/27/2017 Bausch + Lomb And Nicox Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod Read more »
2/21/2017 Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients Read more »
2/1/2017 Bausch + Lomb and Prevent Blindness® Urge Americans to Fight for Their Sight Read more »
1/30/2017 Valeant To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance Read more »
1/26/2017 Bausch + Lomb Specialty Vision Products Introduces ScleralFil™ Solution for Scleral Lens Insertion Read more »
1/18/2017 Bausch + Lomb Introduces Zen™ RC Scleral Contact Lenses Read more »
1/17/2017 Bausch + Lomb Successfully Defends Patent Covering PreserVision® Eye Vitamins in Case vs. Vitamin Health, Inc. Read more »
1/10/2017 Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA® For Presbyopia Contact Lenses Read more »
1/10/2017 Bausch + Lomb ULTRA® for Presbyopia Contact Lenses Parameters Expanded Read more »
12/21/2016 Bausch + Lomb Raises $40K+ for Optometry Giving Sight in Support of 2016 World Sight Day Challenge Read more »
12/12/2016 Bausch + Lomb Specialty Vision Products Launches New 28 Lens Zenlens™ Dx Set Read more »
11/9/2016 Bausch + Lomb and TerraCycle Give Patients a Chance to Contribute to a Greener Future, ONE by ONE, by Recycling their Contact Lenses Read more »
11/8/2016 Valeant Reports Third Quarter 2016 Financial Results Read more »
10/20/2016 Bausch + Lomb Vision Care Joins Volunteer Optometric Service to Humanity of Pennsylvania to Deliver Eye Care to Haiti Read more »
10/17/2016 Valeant Announces Third Quarter Financial Results Date And Conference Call Details Read more »
10/12/2016 Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago Read more »
10/10/2016

Bausch + Lomb Introduces ORBSCAN®3 Anterior Segment Analyzer

 Read more »
9/22/2016 Bausch + Lomb Launches Enhanced Pinnacle 360™ Single-Use Instrument Line Read more »
8/9/2016 Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results Read more »
8/9/2016 Bausch + Lomb Announces Availability of First and Only 27-Gauge Diamond Dusted Membrane Scraper and 27-Gauge Directional Laser Probe Read more »
8/2/2016 Bausch + Lomb Announces Availability of Illuminated Directional Laser Probe Read more »
7/22/2016 Valeant Pharmaceuticals Receives Complete Response Letter From The FDA Read more »
7/18/2016 Bausch + Lomb Brings Home the Gold at North American SABRE Awards Read more »
7/15/2016 Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details Read more »
7/13/2016 Bausch + Lomb Announces Launch of EZ-24 Easy-Load Lens Delivery System for SofPort® Advanced Optics Intraocular Lenses Read more »
7/11/2016 Bausch + Lomb Introduces Enhanced Online Rebate Program Read more »
7/6/2016 Bausch + Lomb and Nicox Announce the Publication of Latanoprostene Bunod Ophthalmic Solution 0.024% Phase 3 Study Results in American Journal of Ophthalmology Read more »
6/30/2016 New Bausch + Lomb Data Shows Outstanding Results for Presbyopic Patients in the Real World Read more »
6/27/2016 Canadian Shopper Study Names Bausch + Lomb Most Trusted Brand For Contact Lens Care Read more »
6/16/2016 Bausch + Lomb Introduces PreserVision® AREDS 2 Formula + Multivitamin Read more »
6/16/2016 Valeant Pharmaceuticals Announces Launch Of New PreserVision® AREDS 2 Formula + Multivitamin Read more »
5/15/2016 Bausch + Lomb Announces Platinum Sponsorship of the International Keratoconus Academy Read more »
6/7/2016 Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results Read more »
5/23/2016 Bausch + Lomb Wins Walmart "Supplier of the Year" Award Read more »
5/12/2016 Bausch + Lomb Named Exclusive U.S. Distributor of HOYA Surgical Optics’ Intraocular Lens and Injector Portfolio Read more »
5/5/2016 Valeant Pharmaceuticals Announces Collaboration Between Bausch + Lomb And IBM Read more »
5/4/2016 Bausch + Lomb Reports Preliminary 2015 Results of the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Study Read more »
5/4/2016 Bausch + Lomb Receives FDA Approval of TRULIGN® Toric IOL Calculator Enhancements, Announces Capsular Tension Ring Addition, and Showcases Latest Innovations in its Product Portfolio During the ASCRS Annual Meeting in New Orleans Read more »
4/29/2016 Bausch + Lomb Highlights Scientific and Clinical Research during the Association for Research in Vision and Ophthalmology Annual Meeting in Seattle, WA Read more »
4/19/2016 New Bausch + Lomb Campaign Asks Consumers “Are Your Contacts Still Comfortable?” Read more »
3/7/2016 Bausch + Lomb Educates 400+ Eye Care Professionals on the Latest in Contact Lens Technology During B+Lieve™ Innovation Summit Read more »
2/25/2016 Bausch + Lomb ULTRA® for Presbyopia Contact Lenses Introduced During SECO International in Atlanta, GA Read more »
2/3/2016 Americans Share What Inspires Them to Fight to Help Preserve Their Vision Read more »
1/19/016 Bausch + Lomb Donates $50,000 to Optometry Giving Sight Read more »
1/12/2016 Bausch + Lomb Expands Specialty Lens Business with the Addition of Alden Optical Laboratories, Inc. Read more »
1/11/2016 Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source Read more »
12/17/2015 Valeant Provides Financial Guidance Update Read more »
12/16/2015 Valeant Announces New U.S. Fulfillment Agreements With Walgreens; Plans To Further Extend Distribution To Independent Pharmacies Read more »
11/11/2015 Bausch + Lomb Presents Products, Surgical Platforms and Newly Expanded Retina Offerings During the Annual Meeting of the American Academy of Ophthalmology in Las Vegas Read more »
11/10/2015 Bausch + Lomb Announces 2016 Launch of Bausch + Lomb ULTRA® Contact Lenses for Presbyopia Read more »
10/26/2015 Five-Year Results of the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Study Published in JAMA Ophthalmology Read more »
10/23/2015 Valeant Pharmaceuticals To Hold Investor Conference Call On October 26, 2015 Read more »
10/20/2015 Valeant Pharmaceuticals Reports Third Quarter 2015 Financial Results Read more »
10/19/2015 Bausch + Lomb Acquires Doctor’s Allergy Formula Diagnostic System Read more »
10/16/2015 Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Synergetics USA, Inc. Read more »
10/14/2015 Valeant Pharmaceuticals Celebrates the Manufacturing of Four Billion Bottles of Eye Care Products at Bausch + Lomb''s Greenville Solutions Plant Read more »
10/6/2015 Valeant Pharmaceuticals To Announce 2015 Third Quarter Results On October 19, 2015 Read more »
10/6/2015 Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Synergetics USA, Inc. Read more »
9/22/2015 Bausch + Lomb and Nicox Announce FDA Acceptance of New Drug Application for Novel Glaucoma Candidate VESNEO™ (latanoprostene bunod) Read more »
9/17/2015 Bausch + Lomb’s Adjustable Chandelier Fiber for the Stellaris® PC Vision Enhancement System Receives FDA Clearance Read more »
9/3/2015 Valeant Pharmaceuticals To Acquire Synergetics USA Read more »
8/12/2015 Bausch + Lomb Announces 23-Gauge Fragmentation Needle Availability for Stellaris® PC Vision Enhancement System Read more »
8/3/2015 Bausch + Lomb’s VICTUS® Femtosecond Laser Platform Receives 510(k) Clearance from FDA for Enhanced Patient Interface Kit Read more »
7/28/2015 Valeant Pharmaceuticals Presented with Economic Development Support from Rochester Gas & Electric for the Bausch + Lomb ULTRA® Contact Lens Manufacturing Line Expansion in Rochester, NY Read more »
7/24/2015 Valeant Pharmaceuticals Reports Second Quarter 2015 Financial Results Read more »
6/25/2015 Valeant Pharmaceuticals To Announce 2015 Second Quarter Results On July 23, 2015 Read more »
6/23/2015 Bausch + Lomb’s Biotrue® ONEday for Presbyopia Contact Lenses Now Available in Expanded High Add Powers Read more »
6/23/2015 Bausch + Lomb Expands Line of Ocuvite® Eye Vitamin and Mineral Supplements with New Eye Health Gummies for Adults Read more »
6/16/2015 Bausch + Lomb’s TRULIGN® Toric IOL Now Available in Full Diopter Range Read more »
5/18/2015 Bausch + Lomb Announces the Availability of its Enhanced TRULIGN® Toric Intraocular Lens Calculator Read more »
5/6/2015 Bausch + Lomb Reports Resistance Patterns for Key Ocular Pathogens at 2015 ARVO Annual Meeting Read more »
5/3/2015 Bausch + Lomb Presents New Scientific and Clinical Research During the Association for Research in Vision and Ophthalmology Annual Meeting in Denver, CO Read more »
4/30/2015 Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results (PDF Version) Read more »
4/30/2015 Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results Read more »
4/15/2015

Bausch + Lomb Showcases Leading Product and Platform Advancements During the ASCRS Annual Meeting in San Diego, CA

 Read more »
4/14/2015 Bausch + Lomb Expands Portfolio Offering with the Acquisition of Acrivet, the Veterinary Division of S&V Technologies GmbH Read more »
4/10/2015 Valeant Pharmaceuticals To Announce 2015 First Quarter Results On April 29, 2015 Read more »
3/26/2015 Bausch + Lomb Announces Availability of Enhanced BLIS™ Reusable Injector System for enVista® Intraocular Lenses Read more »
3/19/2015 New US Performance Data Demonstrates Bausch + Lomb ULTRA® Contact Lenses are #1 Brand Patients Are Switching To Most Often Read more »
2/23/2015 Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Financial Results Read more »
2/6/2015 Valeant Pharmaceuticals To Announce 2014 Fourth Quarter And Full Year Results On February 24, 2015 Read more »
1/20/2015 Bausch + Lomb Introduces New Software and Advanced OCT Imaging System for VICTUS® Femtosecond Laser Platform Read more »
12/16/2014 Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance Read more »
11/12/2014 Bausch + Lomb Completes Installation of Largest Solar Array in New York’s Finger Lakes Region Read more »
11/6/2014 New Bausch + Lomb Consumer Campaigns Educate Patients on Latest Contact Lens and Lens Care Technology Read more »
11/3/2014 Bausch + Lomb Offers Eye Care Practitioners Convenience Pack for Patient’s Daily Lens-Wear Routine Read more »
10/21/2014 Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results Read more »
10/20/2014 New Study Reveals Eye-Opening Facts about Binge-Watching and Contact Lens Wear Scott Foley, Star of Scandal, Shares His Moments of Vision Discomfort with Binge-Watching Read more »
10/16/2014 Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014 Read more »
10/15/2014 Bausch + Lomb Announces Expanded Power Range for TRULIGN™ Toric IOL and Features Other Pharmaceutical, OTC Products and Surgical Platforms During the Annual Meeting of the American Academy of Ophthalmology in Chicago Read more »
10/6/2014

Bausch + Lomb Introduces ZeroPhaco™ Handpiece for Femtocataract Surgery

 Read more »
9/27/2014 Bausch + Lomb Announces Successful Results from Phase 3 Study of Sub-Micron Loteprednol Etabonate Ophthalmic Gel, 0.38% Read more »
9/26/2014 Bausch + Lomb and Nicox''s Glaucoma Candidate VESNEO™ (latanoprostene bunod) Meets Primary Endpoint in Phase 3 Studies Read more »
9/18/2014 Valeant Acquisition Provides Rich Pipeline for Expansion of Bausch + Lomb U.S. Surgical Portfolio Read more »
9/15/2014 Bausch + Lomb Continues Commitment to Educating Eye Care Professionals on the Latest Contact Lens Technology Read more »
9/9/2014 Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in Rochester Read more »
9/3/2014 Aging is the Only Thing Women See through Reading Glasses Read more »
8/1/2014 Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results Read more »
7/17/2014 Bausch + Lomb's VICTUS® Femtosecond Laser Platform Receives 510(k) Clearance from FDA for Lens Fragmentation Procedure Read more »
6/27/2014 Bausch + Lomb Receives U.S. FDA Clearance for Biotrue® ONEday for Presbyopia Lenses Read more »
6/26/2014 Bausch + Lomb Announces Launch of New Soothe® XP Eye Drops with Restoryl® Mineral Oils Read more »
5/9/2014 Valeant Pharmaceuticals Reports First Quarter 2014 Financial Results Read more »
5/8/2014 Bausch + Lomb Reports Resistance Profiles of Ocular Pathogens in the United States and Canada at 2014 ARVO Annual Meeting Read more »
5/1/2014 Bausch + Lomb Highlights Scientific and Clinical Research in Various Therapeutic Areas during the Association for Research in Vision and Ophthalmology Annual Meeting in Orlando Read more »
4/28/2014 Bausch + Lomb Secures Exclusive License to 3-D Surgical Navigation Technology for Cataract Surgery Read more »
4/25/2014 Valeant Pharmaceuticals To Announce 2014 First Quarter Results On May 8, 2014 Read more »
4/23/2014 Bausch + Lomb Introduces ACTIVATE™ System Control Software and Showcases Other Advancements in its Broad Product Portfolio during the ASCRS Annual Meeting in Boston, MA Read more »
3/24/2014 Bausch + Lomb’s Stellaris® PC Vision Enhancement System Receives 510(k) Clearance for Integrated 532nm Laser Read more »
3/13/2014 Bausch + Lomb Launches PeroxiClear™, the Most-Advanced Peroxide-Based Cleaning and Disinfecting Lens Solution in Almost a Decade Read more »
2/28/2014 Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results Read more »
2/6/2014 Valeant Pharmaceuticals To Announce 2013 Fourth Quarter And Full Year Results On February 27, 2014 Read more »
12/13/2013 Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance Read more »
11/13/2013 Bausch + Lomb Highlights Product and Platform Innovations at the Annual Meeting of the American Academy of Ophthalmology in New Orleans Read more »
10/31/2013 Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results Read more »
10/24/2013 Bausch + Lomb Introduces PureVision®2 Multi-Focal Contact Lenses For Presbyopia Read more »
10/08/2013 Valeant Pharmaceuticals To Announce 2013 Third Quarter Results On October 31, 2013 Read more »
10/3/2013 Valeant Pharmaceuticals Bausch + Lomb Receives U.S. FDA Clearance For Novel Monthly Disposable Contact Lens Read more »
10/3/2013 Valeant Pharmaceuticals Bausch + Lomb Receives U.S. FDA Clearance For Novel Monthly Disposable Contact Lens Read more »
8/22/2013 Bausch + Lomb Launches the First and Only Vitamin and Mineral Supplement that Exactly Matches the Updated AREDS Formula Based on the National Eye Institute’s Age-Related Eye Disease Study 2 (AREDS2) Read more »
8/9/2013 Bausch + Lomb and THERA PEARL Partner to Market Innovative Eye Mask Designed to Help Relieve Common Eye Ailments Read more »
08/07/2013 Valeant Pharmaceuticals Reports 2013 Second Quarter Financial Results Read more »
08/06/2013 Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb Read more »
7/18/2013 Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES) Read more »
07/15/2013 Valeant Pharmaceuticals To Announce 2013 Second Quarter Results On August 7, 2013 Read more »
6/26/2013 Bausch + Lomb Receives Health Canada Medical Device Licence for VICTUS™ Femtosecond Laser Platform Read more »
6/20/2013 New Review Finds That Many Americans Over Age 50 are Not Getting Enough of Key Nutrients in Their Daily Diet to Support Their Eye Health Read more »
6/18/2013 Americans Report Being Left High and Dry While On Computers, In Front of TVs and On the Road Read more »
5/27/2013 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. TO ACQUIRE BAUSCH + LOMB FOR $8.7 BILLION Read more »
5/27/2013 Valeant Pharmaceuticals International, Inc. To Acquire Bausch + Lomb For $8.7 Billion Read more »
5/24/2013 Bausch + Lomb Announces Settlement with the U.S. Department of Justice to Resolve and Conclude ISTA Pharmaceuticals Investigation Read more »
5/21/2013 Bausch + Lomb Receives FDA Approval for the TRULIGN™ Toric Posterior Chamber Intraocular Lens Read more »
5/15/2013 Maria Teresa Hilado Joins Bausch + Lomb Board of Directors Read more »
5/9/2013 Alex Kelly Joins Bausch + Lomb as Vice President Investor Relations Read more »
5/9/2013 Bausch + Lomb Reports Fourth Year of Data on Patterns of Bacterial Resistance in Ocular Infections Read more »
5/2/2013 Bausch + Lomb Introduces INCISE® Microincision Intraocular Lens in Europe Read more »
5/1/2013 Bausch + Lomb to Distribute PhysIOL Trifocal Diffractive and Toric Intraocular Lenses in Key Asian, European and Middle Eastern Markets Read more »
5/1/2013 Bausch + Lomb to Present Wealth of Data at the Association for Research in Vision and Ophthalmology Annual Meeting Read more »
4/26/2013 Former Executive Director, Department of Defense and Department of Veterans Affairs Vision Center of Excellence, Joins Bausch + Lomb Read more »
4/19/2013 Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine Read more »
4/17/2013 Bausch + Lomb Launches PROLENSA™ and Showcases Innovative Additions to its Surgical Product Portfolio at the ASCRS Annual Meeting Read more »
4/16/2013 Leica Microsystems and Bausch + Lomb Sign Global Agreement for Surgical Operating Microscopes Read more »
4/8/2013 Bausch + Lomb Receives FDA Approval for PROLENSA™ (bromfenac ophthalmic solution) 0.07% Read more »
4/3/2013 VICTUS® Femtosecond Laser Platform Receives CE Mark for Corneal Incisions, Penetrating Keratoplasty and Intrastromal Channel Incisions for Intracorneal Ring Segments Read more »
3/22/2013 Bausch + Lomb Files Registration Statement for Proposed Initial Public Offering Read more »
3/13/2013 Bausch + Lomb and Walgreens Collaborate to Heighten Eye Health Awareness Read more »
3/6/2013 Presentation of the Phase 2b Results for Glaucoma Drug Candidate Latanoprostene Bunod Read more »
2/26/2013 Bausch + Lomb Names Robert Bertolini President and Chief Financial Officer Read more »
2/14/2013 Bausch + Lomb Announces In-Office Promotion The “Ultimate Movie Experience Sweepstakes” to Introduce Patients to PureVision®2 and SofLens® Daily Disposable Contact Lenses Read more »
2/13/2013 VICTUS™ Femtosecond Laser Platform from Bausch + Lomb Technolas Receives 510(k) Clearance from FDA for Arcuate Incision Procedure Read more »
1/29/2013 Bausch + Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate Licensed from Nicox Read more »
1/28/2013 Bausch + Lomb Completes Acquisition of Technolas Perfect Vision GmbH Read more »
1/22/2013 Bausch + Lomb and CROMA Donate Urgently-Needed Eye Drops Read more »
1/8/2013 UPDATED MEDIA ALERT: U.K. Eye Drop Recall Read more »
1/7/2013 Bausch + Lomb Licenses New Technology with Potential to Treat Millions Affected by Ocular Redness Read more »
11/13/2012 27th Annual “Run for Vision” Raises Needed Funds for Eye Bank Association of America to Help Restore Sight Read more »
11/9/2012 Leading US Surgeons Describe Their Experiences With The New VICTUS™ Femtosecond Laser Platform Read more »
11/9/2012 New LOTEMAX® (loteprednol etabonate ophthalmic gel) 0.5% in a Gel Drop Formulation Available in Pharmacies January 2013 Read more »
11/8/2012 Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology Read more »
11/7/2012 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH Read more »
11/1/2012 Be Aware and Drive Away the Glare Read more »
10/1/2012 Bausch + Lomb Receives FDA Approval of LOTEMAX® (loteprednol etabonate ophthalmic gel) 0.5% Gel Drop Formulation Read more »
9/26/2012 Bausch + Lomb and Lions Clubs International Foundation Award US$150,000 Grant to Siliguri Greater Lions Eye Hospital Read more »
9/19/2012 Besivance® (besifloxacin ophthalmic suspension) 0.6% Receives Additional Indications, Including the Treatment of Bacterial Conjunctivitis Infections Due to Pseudomonas aeruginosa Read more »
9/10/2012 Bausch + Lomb Introduces enVista® TORIC Intraocular Lens In Europe Read more »
8/6/2012 Bausch + Lomb and Technolas™ Perfect Vision Receive 510(k) FDA Clearance from FDA for VICTUS™ Femtosecond Laser Platform Read more »
7/18/2012 Globally, We Are Losing Sight of Our Eye Health, a New Public Opinion Poll Reveals Read more »
6/29/2012 Bausch + Lomb Celebrates 25th Anniversary of renu® Multi-Purpose Solution Brand Read more »
6/28/2012 Bausch + Lomb Receives US FDA Clearance for Biotrue™ ONEday Contact Lenses Read more »
6/20/2012 Bausch + Lomb Receives FDA Approval of the enVista™ Intraocular Lens Read more »
6/18/2012 Bausch + Lomb Submits New Drug Application for Once-Daily PROLENSA™ to Treat Ocular Inflammation and Pain Following Cataract Surgery Read more »
6/6/2012 Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals Read more »
5/25/2012 Bausch + Lomb Launches Biotrue™ ONEday Contact Lenses Made From Breakthrough HyperGel™ Material Read more »
5/22/2012 Bausch + Lomb Opens Philippine Office to Deliver Eye Health Solutions to Doctors and Patients Read more »
5/10/2012 Advanced Loteprednol Etabonate Gel Formulation May Offer New Option for Ocular Inflammation Read more »
5/10/2012 Besifloxacin Demonstrated Potent Activity, High Rate of Eradication Against Multi-drug Resistant Organisms that Cause Eye Infections, According to Data from 2012 ARVO Annual Meeting Read more »
4/21/2012 Bausch + Lomb Unveils New Line of Storz™ CapsuleGuard® IA Handpieces at 2012 ASCRS Read more »
3/26/2012 Bausch + Lomb to Acquire ISTA Pharmaceuticals Read more »
3/13/2012 NicOx, Bausch + Lomb Glaucoma Candidate BOL 303259 X Meets Primary Endpoint in Phase 2b Study Read more »
12/6/2011 Bausch + Lomb and Technolas™ Perfect Vision Announce CE Mark Approval for VICTUS™ Femtosecond Laser Platform Read more »
12/1/2011 Bausch + Lomb Acquires Waicon Read more »
11/29/2011 Consumers Use Unconventional Alternatives for Contact Lens Solution Read more »
11/1/2011 New Survey Shows That People Don’t Want to Live a Moment of Life with Poor Eye Sight Read more »
10/17/2011 WebMD, Bausch + Lomb Join Forces to Help Consumers and Doctors Improve Eye Health Read more »
9/26/2011 Bausch + Lomb Launches LOTEMAX® Ointment (loteprednol etabonate ophthalmic ointment 0.5%) Read more »
9/17/2011 Bausch + Lomb Introduces enVista™ Glistening-Free, Hydrophobic IOL in European Union Read more »
9/14/2011 Bausch + Lomb and Technolas™ Perfect Vision Introduce VICTUS™ Femtosecond Laser Platform at 2011 ESCRS Meeting Read more »
9/8/2011 Bausch + Lomb Enters Into Definitive Agreement with Technolas Perfect Vision GmbH Acquiring An Option to Purchase Company Read more »
7/20/2011 Majority of Moms Are Prepared to Have the “Big Talks” but Unprepared for Those that May Impact Their Child’s Self-Confidence Read more »
6/30/2011 Bausch + Lomb Launches Pharmaceuticals Business in India Read more »
6/15/2011 New Wettability Study Provides Insights into Common Complaint Among Contact Lens Users Read more »
6/15/2011 Patients Report BiotrueTM Makes Contact Lens Wear Easier On Their Eyes Read more »
6/15/2011 Bausch + Lomb’s “The Daily Score” Will Make Daily Disposable Contact Lenses More Accessible to Moms and Kids Across the Country Read more »
6/1/2011 Bausch + Lomb Storz® Ophthalmics Introduces New Collection of StableGrip™ Vitreoretinal Instruments Read more »
6/1/2011 Yellox™ (Bromfenac sodium sesquihydrate), the First and Only Twice-Daily Ocular NSAID, Approved by the European Commission Following Positive Opinion from CHMP Read more »
5/26/2011 Glare and Halos Are Significant Problems for People Wearing Glasses or Contact Lenses Read more »
5/20/2011 Bausch + Lomb and Lions Clubs International Foundation Bring Sight-Saving Prevention and Treatment Programs to Tianjin Hospital in China Read more »
4/27/2011 Yellox™ (Bromfenac) Receives Positive CHMP Opinion in the European Union (EU) Read more »
3/25/2011 Bausch + Lomb and Technolas Perfect Vision Announce Agreement in Principle to Distribute the First Femtosecond Laser Capable of Performing Both Cataract and Refractive Surgery on One Platform Read more »
3/23/2011 Florence Henderson to be Featured with Bausch + Lomb’s Crystalens® at ASCRS Read more »
3/9/2011 Early Vision Screenings and Eye Exams Help Save Kids’ Sight Read more »
3/9/2011 Bausch + Lomb Storz® Ophthalmics Introduces the Osher Sterile Field Magnifier Read more »
2/24/2011 Bausch + Lomb Introduces the Putterman Consecutive CDCR Set Read more »
2/3/2011 Partnership Announces Inaugural Research Grants to Fight Childhood Blindness Read more »
1/31/2011 Keep Your Kids’ Eyes Safe During Spring Sports Season Read more »
1/28/2011 Bausch + Lomb Announces Global Licensing Agreement with UltraVision CLPL to Market KeraSoft® Contact Lenses Read more »
1/26/2011 Bausch + Lomb Manufacturing Sites in Florida Achieve Globally Recognized Certifications for Environment, Health, and Safety Management Read more »
1/25/2011 Global Study Reveals Patients’ Vision Care Priorities Read more »
1/24/2011 Bausch + Lomb Storz® Ophthalmics Introduces Additions to its Single-Use Vitreoretinal Instruments Line Read more »
1/10/2011 Bausch + Lomb Offers Crystalens® iClear iPhone Application Read more »
12/20/2010 Bausch + Lomb Extends Crystalens® Patient Rebate Program Read more »
12/8/2010 Tips to Keep Kids’ Eyes Safe This Holiday Season Read more »
12/8/2010 Bausch + Lomb Storz® Ophthalmics Introduces a New Line of Single-Use Cataract Instruments Read more »
11/18/2010 Bausch + Lomb Recommends a “Rub and Rinse” Regimen for Disinfection and Cleaner Contact Lenses Read more »
11/11/2010 Bausch + Lomb Storz® Ophthalmics Enhances Instrument Web Sites with E-Commerce System Read more »
11/1/2010 VSP Vision Care and Bausch + Lomb Bring Value to Members Read more »
10/14/2010 New Design of Bausch + Lomb PreserVision® Eye Vitamin AREDS 2 Formula Released Read more »
10/12/2010

Parents: Top Tips for Infant Eye Health

Read more »
9/29/2010 Bausch + Lomb Storz® Ophthalmic Instruments Launches Innovative Incision Technology with Tru-Size™ Diamond Knife Read more »
9/21/2010 Bausch + Lomb Storz® Ophthalmics Launches the Whitman Double-Ended LRI Marker Read more »
9/20/2010 Bausch + Lomb Completes Acquisition of Miochol®-E Read more »
9/14/2010 Actress Florence Henderson to Visit Two Florida Cities for Bausch + Lomb's Crystalens'®' Read more »
9/13/2010

Bausch + Lomb Launches Cataract Education Web Site

Read more »
9/8/2010

Pediatric Cataract Initiative Seeking Applicants for Inaugural Research Grant

Read more »
9/7/2010 Bausch + Lomb and Florence Henderson Announce Partnership Read more »
9/3/2010 Bausch + Lomb to Acquire Miochol®-E Read more »
9/1/2010 Dr. Wing-Kun Tam Named to Pediatric Cataract Initiative’s Global Advisory Council Read more »
8/31/2010 Bausch + Lomb Launches New Alaway® Television Ads Read more »
8/31/2010 Bausch + Lomb Releases Single–Use Vitreoretinal Asymmetric Peeling Forceps Read more »
8/23/2010 Bausch + Lomb Introduces the Stellaris® PC Vision Enhancement System for Retinal Surgery Read more »
8/9/2010 Bausch + Lomb Celebrates New Biotrue™ Multi-Purpose Lens Solution with FREE Admission for Thousands to Some of America’s Most Visually Inspiring Attractions Read more »
8/3/2010 Bausch + Lomb Teams Up with Actress Marcia Gay Harden to Encourage Parents to Make Vision Care a Priority for Back-to-School Read more »
8/3/2010 Bausch + Lomb Introduces the Stellaris® PC Vision Enhancement System Read more »
7/22/2010 Voluntary Recall of PreserVision® Eye Vitamin AREDS 2 Formula in the United States Read more »
6/29/2010 New Campaign to Fight Childhood Blindness Comes to Australia Read more »
6/21/2010 Actor Florence Henderson Discusses Eye Surgery and Crystalens'®' Read more »
6/17/2010 Biotrue™: A Unique Concept in Lens Care Launches in the United States Read more »
6/17/2010 Biotrue™: A Unique Concept in Lens Care Launches in Europe Read more »
6/16/2010 Bausch + Lomb and Lions Clubs Partner to Fight Childhood Blindness Read more »
6/16/2010 Pediatric Cataract Initiative Names Global Advisory Council Read more »
6/3/2010 Bausch + Lomb Acquires Zirgan® (Ganciclovir Ophthalmic Gel 0.15%) from Sirion Therapeutics for the Treatment of Herpetic Keratitis Read more »
5/25/2010 Bausch + Lomb Storz® Ophthalmics Launches Enhanced Rebranded Web Sites Read more »
5/21/2010 Bausch + Lomb Launches Innovative New Toric Eye-App Calculator for the iPhone, iPod Touch and Online Read more »
5/17/2010 Crystalens® AO Receives Quarter Diopter Approval Read more »
5/4/2010 Bausch + Lomb Introduces New Soothe® Xtra Hydration Dry Eye Therapy Lubricant Eye Drops Read more »
4/20/2010 Bausch + Lomb and Christine Baranski Team Up to Say Goodbye Reading Glasses, Hello Hollywood Read more »
4/15/2010 Crystalens® AO Receives NTIOL Classification From CMS Read more »
4/12/2010 Bausch + Lomb Reinvigorates Multi-Purpose Solution Portfolio to Enable Asian Consumers to Make a Clearer Choice Read more »
4/9/2010 Bausch + Lomb Introduces New PreserVision® Eye Vitamin and Mineral Supplement Read more »
4/9/2010 Crystalens® To Celebrate Major Milestones at a National Eye Surgery Meeting in Boston Read more »
4/7/2010 Cataract Surgeons to Observe and Discuss Live Eye Surgery this Friday at ASCRS Annual Meeting Read more »
3/19/2010 Bausch + Lomb Relaunches renu® fresh™ Multi-Purpose Solution, Now Available in a Clear Bottle Read more »
3/17/2010 Bausch + Lomb Wins Global Award for Revolutionary Bottle Design Read more »
3/9/2010 Bausch + Lomb Announces Ongoing Grant Support to Cornea and Contact Lens Residents Read more »
3/9/2010 Bausch + Lomb and AOF Announce Recipients of 2009-2010 William C. Ezell Fellowships Read more »
3/3/2010

NicOx and Bausch + Lomb Announce Worldwide Licensing Agreement for NCX 116

Read more »
2/12/2010 Bausch + Lomb Releases Single-Use Silicone I/A Handpieces Read more »
1/6/2010 Bausch + Lomb Introduces New Corporate Logo and Icon Read more »
1/4/2010 Bausch & Lomb Introduces the Crystalens® Aspheric Optic (AO) Lens Read more »
12/16/2009 Bausch & Lomb Releases E2407 Raviv Capsulorhexis Caliper Read more »
12/10/2009 Bausch & Lomb Releases E2013T MICS™ Capsulorhexis Forceps with Seibel Ruler Read more »
12/7/2009 Bausch & Lomb Releases Single-Use Endgripping Forceps for Vitreoretinal Surgery Read more »
11/12/2009 Clinical Studies Show Bausch & Lomb's Lo-Torque® Design Delivers Better Rotational Recovery to Help Maintain More Consistent Vision than Acuvue Accelerated Stabilization Design Read more »
11/10/2009 Visionary New Eye Product Launched by Bausch & Lomb in the United Kingdom Read more »
11/9/2009 Bausch & Lomb Unveils FogShield Sport, an Anti-Fog Treatment for Sports Goggles That Works Read more »
10/15/2009 Center for Patient Insights Web Site Goes Live Read more »
10/5/2009 Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux Read more »
9/28/2009 Bausch & Lomb Subsidiaries and CROMA will Co-Promote Bromfenac Ophthalmic Solution in Europe Read more »
9/23/2009 Bausch & Lomb Launches Enhanced U.S. eCommerce Web Site for Eye Care Professionals Read more »
9/15/2009 Bausch & Lomb SofLens® Daily Disposable Contact Lenses Partners with Shutterfly to Find the Most Eye-Catching Photo of the Summer Read more »
9/14/2009 Bausch & Lomb’s Crystalens® to be Featured in Direct-to-Consumer Advertising Read more »
9/9/2009 Survey Sheds Light on Rotational Recovery Issues for Soft Toric Contact Lens Wearers Read more »
9/2/2009 Bausch & Lomb Releases ET2057 Singh Akahoshi Prechop Forceps with Paddle Tip Read more »
8/12/2009 Bausch & Lomb Releases E2960 Brown Crystalens® Haptic Placement Forceps and E0529 Lindstrom Lens Positioner Read more »
8/3/2009 Bausch & Lomb Surgical Launches the Akreos® AO Micro Incision IOL Read more »
7/20/2009 Governor Corzine and Bausch & Lomb Celebrate Grand Opening of New Pharmaceutical Headquarters Read more »
7/13/2009 Bausch & Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps Read more »
7/9/2009 Bausch & Lomb Multi-Focal Web Site Awarded “Best in Class” in Healthcare Category of the 2009 Interactive Media Award Read more »
7/7/2009 Bausch & Lomb Releases Whitman Shepherd Double-Ended Capsule Polisher Read more »
6/26/2009 Bausch & Lomb Announces New Center for Patient Insights Read more »
6/26/2009 Bausch & Lomb Kicks Off U.S. Consumer Online Marketing Campaign for SofLens® Daily Disposable Contact Lenses Read more »
6/26/2009 Bausch & Lomb Vision Care Strengthens Its Commitment to ReNu® Brand and the Eye Care Community Read more »
6/25/2009 Bausch & Lomb Launches Wallace LRI Set Read more »
6/25/2009 Bausch & Lomb Launches Silverstein Instruments for MICS™ 1.8mm Surgery Read more »
6/22/2009 Bausch & Lomb Canada Introduces PrLotemax™ and PrAlrex® Read more »
5/29/2009 Bausch & Lomb Receives FDA Approval of Besivance™, New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (“Pink Eye”) Read more »
5/15/2009 Bausch & Lomb Announces New Surgical Instruments Web Sites Read more »
5/14/2009 Bausch & Lomb Announces Agreement with Karl Storz GmbH & Co. for ENT and Plastic Surgery Instrument Naming Read more »
5/11/2009 Bausch & Lomb Akreos® AO IOL Granted New Technology Intraocular Lens (NTIOL) Designation Read more »
4/30/2009 Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture Read more »
4/29/2009 Bausch & Lomb Launches New Bottle Innovation in Europe Supported By Eye-Catching Online Campaign Read more »
4/2/2009 Surgeons to Observe and Discuss Live Eye Surgery Friday Night in San Francisco Read more »
4/1/2009 Bausch & Lomb Launches Instrument CE Programs Read more »
3/30/2009 Bausch & Lomb Partners with Visual Therapy to Help Women Nationwide "See A New You" Read more »
3/16/2009 Bausch & Lomb, Sight Savers® Brand Products Receive COLTS Laboratories Performance Certification Read more »
3/12/2009 Bausch & Lomb Launches Multi-Tiered U.S. Consumer Education Initiative To Raise Awareness of Presbyopia Read more »
3/3/2009 Bausch & Lomb and Pfizer to Co-Promote Products for the Treatment of Ophthalmic Conditions Read more »
3/3/2009 Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development Read more »
2/28/2009 Bausch & Lomb asks Europe: Do You have "The Winning Look"? Read more »
2/4/2009

Bausch & Lomb's Crystalens to be Featured in Florida Advertising Campaign
 		Read more »
2/2/2009 Bausch & Lomb Survey Shows Astigmats Uninformed About Contact Lens Wear Read more »
12/5/2008 FDA Advisory Committee Recommends Approval of Bausch & Lomb's Besifloxacin Anti-Infection Eye Drop Read more »
10/23/2008 Bausch & Lomb Highlights SofLens® Daily Disposable Contact Lenses at American Academy of Optometry Annual Meeting Read more »
9/15/2008 FDA Approves Akreos™ Advanced Optics Aspheric Lens Read more »
9/12/2008 Bausch & Lomb celebrates 10 years of Akreos® IOL design innovation in Europe at ESCRS 2008 Read more »
9/12/2008 Bausch & Lomb Introduces the Crystalens® HD Accommodating Intraocular Lens to Europe at ESCRS 2008 Read more »
9/12/2008 Bausch & Lomb Announces European Launch of Innovative Zyoptix® Advanced Control Eyetracking (ACE™) Technology at the ESCRS 2008 Read more »
9/8/2008 Bausch & Lomb and 20/10 Perfect Vision Intend to Form Refractive Surgery Joint Venture Read more »
9/2/2008 Bausch & Lomb Limited Edition Pink Crystallized - Swarovski Elements Contact Lens Cases Benefit Susan G. Komen for the Cure Read more »
6/30/2008 CRYSTALENS HD™ RECEIVES FDA APPROVAL Read more »
4/11/2008 Bausch & Lomb Partners With Optometric Community To Benefit Breast Cancer Research Read more »
4/10/2008 Bausch & Lomb and Galapagos Sign Agreement to Collaborate on Ophthalmic Disease Research Read more »
4/7/2008 Bausch & Lomb Lens Wins 2008 Medical Design Excellence Awards Competition Read more »
4/2/2008 Gift of Sight Given to 100 People in 100 Minutes Read more »
3/11/2008 Bausch & Lomb Researchers Awarded Highest Scientific Honor from Chinas Shandong Institute of Pharmaceutical Research Read more »
2/20/2008 Bausch & Lomb Announces Positive Clinical Results for Zylet® in a Comparison of Safety and Efficacy with Tobradex in the Treatment of Blepharokeratoconjunctivitis Read more »
2/1/2008 Bausch & Lomb Completes Acquisition of eyeonics, inc. Read more »
1/28/2008 Bausch & Lomb and CrystalGenomics Announce R&D Collaboraton Read more »
1/20/2008 Bausch & Lomb to Acquire eyeonics, inc.(tm) Read more »
12/10/2007 Bausch & Lomb Introduces New Presbyopic Web Resource Read more »
11/16/2007 Run for Vision Nets Record Participation and Proceeds for the Eye Bank Association of America Read more »
11/9/2007 Shift to Sub-2 mm Microincision Cataract Surgery Designed to Speed Vision Recovery Read more »
10/25/2007 Bausch & Lomb Educates Dieticians about Ocuvite Vitamins at the American Dietetic Association Food and Nutrition Conference Read more »
10/25/2007 Bausch & Lomb Highlights Its Newest Lines of Eye Care Products at Annual American Academy of Optometry Conference Read more »
9/26/2007 Bausch & Lomb Partners with Susan G. Komen for the Cure Read more »
9/7/2007 Bausch & Lomb Launches the Stellaris(tm) Vision Enhancement System in Europe at ESCRS 2007 Read more »
9/5/2007 Bausch & Lomb Honored by Hispanic Business and LATINA Style for Diversity Initiatives Read more »
8/1/2007 Bausch & Lomb Acquires Soothe® Emollient (Lubricant) Eye Drops from Alimera Sciences Read more »
6/28/2007 Bausch & Lomb Introduces Ocuvite® DF Eye Vitamin Supplement for Diabetics Read more »
5/23/2007 Bausch & Lomb Names Joe Barr Vice President, Global R&D Vision Care Read more »
5/17/2007 Bausch & Lomb Announces New U.S. Sales Organization Responsible for Full Retina Portfolio Read more »
1/23/2007 Bausch & Lomb’s Retisert® Drug Implant Receives Product Specific Billing Code and Medicare Reimbursement Rate Read more »
1/15/2007 Bausch & Lomb Announces Strategic Alliance with AcuFocus For Presbyopic Correction Technology Read more »